Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|6 Sep 2016||Submitted||Original manuscript|
|30 Sep 2016||Reviewed||Reviewer Report - Allan Lipton|
|26 Nov 2016||Reviewed||Reviewer Report - Linda Connelly|
|16 Dec 2016||Reviewed||Reviewer Report - Molin Wang|
|20 Dec 2016||Author responded||Author comments - Renée Fortner|
|Resubmission - Version 2|
|20 Dec 2016||Submitted||Manuscript version 2|
|21 Dec 2016||Author responded||Author comments - Renée Fortner|
|Resubmission - Version 3|
|21 Dec 2016||Submitted||Manuscript version 3|
|29 Dec 2016||Reviewed||Reviewer Report - Linda Connelly|
|9 Jan 2017||Reviewed||Reviewer Report - Molin Wang|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|10 Jan 2017||Editorially accepted|
|8 Feb 2017||Article published||10.1186/s12916-017-0786-8|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.